TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14624219

Group type: EXPERIMENTAL
Intervention: Misoprostol (20-40 microg) for induction of labor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol as a single agent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol for postpartum hemorrhage
Number of subjects: 0
Study: 11192134

Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release (once-daily for 14 days)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Clarithromycin immediate-release (twice-daily for 14 days)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release
Number of subjects: 283

Group type: COMPARATOR
Intervention: Clarithromycin immediate-release
Number of subjects: 283
Study: 9201523

Group type: EXPERIMENTAL
Intervention: S. boulardii 500 mg four times a day
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: S. boulardii 500 mg four times a day (after adjustment for risk factors)
Number of subjects: 128
Study: 7835781

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (no hormonal treatment)
Number of subjects: 105
Study: 2972171

Group type: EXPERIMENTAL
Intervention: Danazol (200 mg, 3 times daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose Medroxyprogesterone Acetate (MPA) (100 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29698440

Group type: EXPERIMENTAL
Intervention: Multiple-modality exercise with additional mind-motor training (M4, n = 63)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (balance, range of motion and breathing exercises [M2, n = 64])
Number of subjects: 127
Study: 24239455

Group type: EXPERIMENTAL
Intervention: Sleep onset insomnia (SOI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sleep maintenance insomnia (SMI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Good sleepers (GS)
Number of subjects: 30
Study: 22803412

Group type: EXPERIMENTAL
Intervention: Surgery plus Radiochemotherapy (surgery group)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Radiochemotherapy (conventional group)
Number of subjects: 104
Study: 19628570

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years
Number of subjects: 672

Group type: COMPARATOR
Intervention: Placebo for 5 years
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Tamoxifen and Placebo
Number of subjects: 672
Study: 18495848

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 15815224

Group type: EXPERIMENTAL
Intervention: Nurse Case Manager (NCM) Model (Ward A)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Team nursing (Ward B)
Number of subjects: 145
Study: 12799617

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (risperidone, clozapine, olanzapine, quetiapine)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 10513172

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (LR group, n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Acetated Ringer's solution (AR group, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 20
Study: 7718072

Group type: EXPERIMENTAL
Intervention: Community-based injury prevention program in Harstad, implemented over three periods of 30 months each, with increasing preventive efforts.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonequivalent control city (Trondheim) with no active intervention.
Number of subjects: 0
Study: 2119446

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) with standard amino acids (1.5 g/kg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Isocaloric isonitrogenous TPN with added branched‐chain amino acids
Number of subjects: 28

Group type: COMPARATOR
Intervention: No nutritional support
Number of subjects: 28
Study: 6987418

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride or amitriptyline hydrochloride
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control values (not specified)
Number of subjects: 59
Study: 30737894

Group type: EXPERIMENTAL
Intervention: Short bouts of moderate physical activity (SBP) - two 25-minute bouts of moderate-intensity PA 6 d/wk
Number of subjects: 65

Group type: COMPARATOR
Intervention: Long bout of moderate physical activity (LBP) - one 50-minute bout of moderate-intensity PA 6 d/wk
Number of subjects: 65
Study: 28091696

Group type: EXPERIMENTAL
Intervention: Tin prefiltration (200 mAs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard protocol without spectral shaping (25 mAs)
Number of subjects: 100
Study: 25662039

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 23826157

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment for 12 weeks
Number of subjects: 117
Study: 22211210

Group type: EXPERIMENTAL
Intervention: Seclusion (N=12)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mechanical restraint (N=14)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Seclusion (Cohort arm, N=48)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Mechanical restraint (Cohort arm, N=28)
Number of subjects: 102
Study: 19125101

Group type: EXPERIMENTAL
Intervention: Resisted sprint (RS) training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no RS training)
Number of subjects: 15
Study: 17361345

Group type: EXPERIMENTAL
Intervention: Strength training of elbow flexors and ankle dorsiflexors
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Albuterol (sustained-release, 8 mg bid)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Non-training (control group)
Number of subjects: 65
Study: 15533268

Group type: EXPERIMENTAL
Intervention: Jarlsberg cheese (CH diet)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Butter + calcium caseinate (BC diet)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Butter + egg-white protein (BE diet)
Number of subjects: 22
Study: 11345161

Group type: EXPERIMENTAL
Intervention: AIDA simulator (active intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional educational methods (control group)
Number of subjects: 0
Study: 9238064

Group type: COMPARATOR
Intervention: Lupron alone (gonadotropin-releasing hormone agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lupron plus progesterone replacement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lupron plus estradiol replacement
Number of subjects: 0
Study: 8116741

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (five injections of 5 mg during two weeks after surgery)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no 5-fluorouracil)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Number of subjects: 44
Study: 3335990

Group type: EXPERIMENTAL
Intervention: Pregestimil
Number of subjects: 6

Group type: COMPARATOR
Intervention: Alfare
Number of subjects: 6
Study: 30460936

Group type: EXPERIMENTAL
Intervention: Barbed sutures
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional sutures (Vicryl)
Number of subjects: 84
Study: 28068186

Group type: EXPERIMENTAL
Intervention: PDT+chitosan 3 mg/mL
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: PDT
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: NaOCl (2.5%)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Positive control (no treatment)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Negative control (no inoculation, no treatment)
Number of subjects: 102
Study: 25889633

Group type: EXPERIMENTAL
Intervention: sulphadoxine-pyrimethamine + artesunate (SP + AS)
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: sulphadoxine-pyrimethamine + amodiaquine (SP + AQ)
Number of subjects: 912

Group type: COMPARATOR
Intervention: sulphadoxine-pyrimethamine alone (SP)
Number of subjects: 912
Study: 24351694

Group type: EXPERIMENTAL
Intervention: Midazolam (doses of at least 0.3 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Midazolam (any dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 21354596

Group type: EXPERIMENTAL
Intervention: Dorsal graft placement (group 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined graft placement (group 2)
Number of subjects: 20
Study: 18335008

Group type: EXPERIMENTAL
Intervention: Combined tool approach using a battery-operated screwdriver and cutting tool as needed
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 84
Study: 16782922

Group type: EXPERIMENTAL
Intervention: Black cohosh (Cimicifuga racemosa 20 mg BID)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 12707092

Group type: EXPERIMENTAL
Intervention: Daily sunscreen application (high-protection sunscreen applied every morning)
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Discretionary sunscreen use
Number of subjects: 1621

Group type: EXPERIMENTAL
Intervention: Beta carotene supplementation (30 mg/day)
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 1621
Study: 10910476

Group type: EXPERIMENTAL
Intervention: Proximal IJV cannulation (≥ 1 cm above the cricoid level)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Distal IJV cannulation (≥ 1 cm below the cricoid level)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Proximal IJV cannulation (≥ 1 cm above the cricoid level) after catheter removal
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Distal IJV cannulation (≥ 1 cm below the cricoid level) after catheter removal
Number of subjects: 91
Study: 8757560

Group type: EXPERIMENTAL
Intervention: Photographic screening tool for FAS facial phenotype
Number of subjects: 42
Study: 1568574

Group type: EXPERIMENTAL
Intervention: Immediate start of steroid tapering (group A; n = 46)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Continued prednisolone treatment for 5 more weeks before tapering (group B; n = 50)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Already in endoscopic remission (group C; n = 40)
Number of subjects: 147
Study: 6232035

Group type: EXPERIMENTAL
Intervention: Etodolac, 600 mg/day
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Etodolac, 800 mg/day
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Etodolac, 1200 mg/day
Number of subjects: 61

Group type: COMPARATOR
Intervention: Aspirin, 2600 mg/day
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 31366643

Group type: EXPERIMENTAL
Intervention: Highly sensitive acupoints group
Number of subjects: 716

Group type: COMPARATOR
Intervention: Low/non-sensitive acupoints group
Number of subjects: 716

Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 716

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 716
Study: 29408818

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultraconservative treatment (UCT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional restorative treatment (CRT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nontreated open cavities
Number of subjects: 50
Study: 26432508

Group type: EXPERIMENTAL
Intervention: Abemaciclib (200 mg orally every 12 hours) with best supportive care (BSC)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Erlotinib (150 mg orally every 24 hours) with best supportive care (BSC)
Number of subjects: 550
Study: 25369006

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22278333

Group type: EXPERIMENTAL
Intervention: Telcagepant 600 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Telcagepant 900 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 20176217

Group type: EXPERIMENTAL
Intervention: Anastomotic connector
Number of subjects: 151

Group type: COMPARATOR
Intervention: Hand-sutured grafts
Number of subjects: 151
Study: 17378909

Group type: EXPERIMENTAL
Intervention: Pantoprazole 8 mg/h continuous IV infusion for 48 h after a bolus of 40 mg
Number of subjects: 164

Group type: COMPARATOR
Intervention: Somatostatin 250 microg/h continuous IV infusion for 48 h after a bolus of 250 microg
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Pantoprazole 8 mg/h continuous IV infusion for 48 h
Number of subjects: 164

Group type: COMPARATOR
Intervention: Somatostatin 250 microg/h continuous IV infusion for 48 h
Number of subjects: 164
Study: 15972934

Group type: EXPERIMENTAL
Intervention: Low toenail chromium concentration (average 1.10 mug/g in cases)
Number of subjects: 684

Group type: COMPARATOR
Intervention: Control group (average toenail chromium concentration 1.30 mug/g)
Number of subjects: 684
Study: 11927145

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 16
Study: 9798443

Group type: EXPERIMENTAL
Intervention: Surgery with anterior plate fixation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Surgery without anterior plate fixation
Number of subjects: 27
Study: 7734253

Group type: EXPERIMENTAL
Intervention: 0.5% halothane
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 0.8% isoflurane
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both agents
Number of subjects: 23
Study: 2711281

Group type: EXPERIMENTAL
Intervention: Iron and folate supplementation during pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron supplementation only during pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Iron only)
Number of subjects: 0
Study: 30300054

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) therapy combined with low-resistance muscular training for 15 weeks
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) therapy combined with low-resistance muscular training for 13 days
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) therapy while immobilized in the early postoperative period
Number of subjects: 3

Group type: COMPARATOR
Intervention: Low-resistance muscular training alone
Number of subjects: 3
Study: 29059673

Group type: EXPERIMENTAL
Intervention: Buffered hypertonic saline (BHS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal saline solution (NSS)
Number of subjects: 36
Study: 25491535

Group type: EXPERIMENTAL
Intervention: CM group (CM combined with FET)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Hysteroscopy group (hysteroscopic endometrial mechanical stimulation)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (conventional FET)
Number of subjects: 168
Study: 22832470

Group type: EXPERIMENTAL
Intervention: Error-augmentation training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Error-reduction training
Number of subjects: 20
Study: 21597360

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with fast track care (FT)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Open surgery with fast track care (FT)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery with standard care
Number of subjects: 400

Group type: COMPARATOR
Intervention: Open surgery with standard care
Number of subjects: 400
Study: 19927096

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 600 U/kg subcutaneously once weekly starting 3 weeks before spinal surgery plus standard of care for blood conservation
Number of subjects: 680

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 680

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 680
Study: 17031007

Group type: EXPERIMENTAL
Intervention: Chitosan (six 500 mg capsules per day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (weight loss programs of their choice)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo group (PLA)
Number of subjects: 150
Study: 14677527

Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg once daily)
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1013
Study: 11051260

Group type: EXPERIMENTAL
Intervention: Doxorubicin 40 mg/m2 followed by Docetaxel 50 mg/m2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Docetaxel 70 mg/m2 followed by Doxorubicin 50 mg/m2
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Docetaxel followed by Doxorubicin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Doxorubicin followed by Docetaxel
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Doxorubicin 50 mg/m2 followed by Docetaxel 60 mg/m2
Number of subjects: 25
Study: 9176438

Group type: EXPERIMENTAL
Intervention: Lignocaine spray
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lignocaine spray and Placebo
Number of subjects: 120
Study: 1439067

Group type: EXPERIMENTAL
Intervention: Captopril + hydrochlorothiazide (CAP + HCTZ) 25 mg once a day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Captopril + nifedipine (CAP + NIF) 20 mg/12 h
Number of subjects: 80
Study: 3540877

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Ketorolac 90 mg
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Morphine 12 mg
Number of subjects: 241

Group type: COMPARATOR
Intervention: Morphine 6 mg
Number of subjects: 241
Study: 29976872

Group type: COMPARATOR
Intervention: Standard Care (LIMIT trial)
Number of subjects: 721
Study: 27040426

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2mA for 20min during twenty days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Anodal tDCS and Lokomat gait training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS and Lokomat gait training
Number of subjects: 24
Study: 24475799

Group type: EXPERIMENTAL
Intervention: Prostatic arterial embolization (PAE)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 114
Study: 22007041

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment with a multifactorial intervention lasting two years
Number of subjects: 781

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 781
Study: 19531276

Group type: EXPERIMENTAL
Intervention: Self-management plus treatment as usual (TAU) (n=31)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) control condition (n=33)
Number of subjects: 64
Study: 18357475

Group type: EXPERIMENTAL
Intervention: 0.1% sorbate (SA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.1% benzoate (BA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine (CHX)
Number of subjects: 24

Group type: COMPARATOR
Intervention: NaCl
Number of subjects: 24
Study: 15824372

Group type: EXPERIMENTAL
Intervention: Indinavir treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11834104

Group type: EXPERIMENTAL
Intervention: Flexible magnet (700‐G intensity)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham magnet (placebo)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Baseline (no magnet)
Number of subjects: 35
Study: 10402766

Group type: EXPERIMENTAL
Intervention: Chemotherapy (cisplatin 70 mg/m2 on day 1, fluorouracil 700 mg/m2 and leucovorin 20 mg/m2 on days 1 to 5)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Surgery (immediate surgery without chemotherapy)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 42
Study: 7733763

Group type: EXPERIMENTAL
Intervention: pH-stat protocol
Number of subjects: 70

Group type: COMPARATOR
Intervention: alpha-stat protocol
Number of subjects: 70
Study: 2382805

Group type: EXPERIMENTAL
Intervention: Alfentanil and droperidol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fentanyl and droperidol
Number of subjects: 40
Study: 6114884

Group type: EXPERIMENTAL
Intervention: Carbuterol 3 mg thrice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Carbuterol 2 mg thrice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Salbutamol 4 mg thrice daily
Number of subjects: 30
Study: 31285359

Group type: EXPERIMENTAL
Intervention: Systematic case-finding programme
Number of subjects: 1

Group type: COMPARATOR
Intervention: Current routine diagnostic process
Number of subjects: 1
Study: 28050801

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg (D4)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg (D10)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (normal saline [NS])
Number of subjects: 69
Study: 25262375

Group type: EXPERIMENTAL
Intervention: Educational video about intrauterine devices (IUDs)
Number of subjects: 315
Study: 23059868

Group type: EXPERIMENTAL
Intervention: CADENCE
Number of subjects: 180

Group type: COMPARATOR
Intervention: SELF
Number of subjects: 180

Group type: COMPARATOR
Intervention: FREQUENCY
Number of subjects: 180
Study: 21255753

Group type: EXPERIMENTAL
Intervention: Topically applied Eutectic mixture of local anesthetics (EMLA) during tDCS stimulation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo cream during tDCS stimulation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cathodal stimulation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Anodal stimulation
Number of subjects: 9
Study: 18974529

Group type: EXPERIMENTAL
Intervention: Zeiss AT 030 (GATZ)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Inami L‐5110 (GATI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of GATZ and GATI
Number of subjects: 40
Study: 17054744

Group type: EXPERIMENTAL
Intervention: New fixed combination of mefloquine and artesunate
Number of subjects: 500

Group type: COMPARATOR
Intervention: Separate tablets of mefloquine and artesunate
Number of subjects: 500
Study: 15189956

Group type: COMPARATOR
Intervention: β2-agonist (single dose)
Number of subjects: 33

Group type: COMPARATOR
Intervention: β2-agonist (longer duration trials)
Number of subjects: 33
Study: 11588611

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.5 Hz rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 18